Sandbox Reserved 490: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
Line 28: Line 28:
Estrogen receptors have two important structural components: the DNA-binding domain and the ligand-binding domain.  
Estrogen receptors have two important structural components: the DNA-binding domain and the ligand-binding domain.  


''DNA-Binding domain''
''DNA-Binding domain[http://www.rcsb.org/pdb/explore/explore.do?structureId=1hcq]''


<Structure load='1hcq' size='500' frame='true' align='right' caption='ER DBD' scene='' />
<Structure load='1hcq' size='500' frame='true' align='right' caption='ER DBD' scene='' />
Line 71: Line 71:




''Ligand-binding domain''
''Ligand-binding domain[http://www.rcsb.org/pdb/explore/jmol.do?structureId=1A52&bionumber=1]''


<Structure load='1a52' size='500' frame='true' align='right' caption='ER LBD' scene='Insert optional scene name here' />
<Structure load='1a52' size='500' frame='true' align='right' caption='ER LBD' scene='Insert optional scene name here' />
Line 81: Line 81:
The ligand used to determine this structure was estradiol, which is the physiologically appropriate ligand. Estradiol, or estrogen, has the following structure:
The ligand used to determine this structure was estradiol, which is the physiologically appropriate ligand. Estradiol, or estrogen, has the following structure:


[[Image:content.answcdn.com/main/content/img/oxford/oxfordBiochemistry/0198529171.17b-estradiol.1.jpg]]
[[Image:http://content.answcdn.com/main/content/img/oxford/oxfordBiochemistry/0198529171.17b-estradiol.1.jpg]]
 
 
==Mechanism of Action==